Bn. Chau et al., THE EGF RECEPTOR-BINDING OF RECOMBINANT HEREGULIN-BETA-1 EGF HYBRIDS IS BLOCKED BY HEREGULIN RESIDUE GLUTAMATE-195/, Biochemical and biophysical research communications, 229(3), 1996, pp. 882-886
Defined sequences from the EGF-like domain of human heregulin-beta 1 (
HRG beta 1) were recombined with a synthetic gene fro human epidermal
growth factor (hEGF) in an attempt to locate receptor-specific determi
nants within the HRG beta 1 molecule that blocks its inappropriate ass
ociation with the EGF receptor (EGFR). Receptor competition assays det
ected only minor changes in relative EGFR affinity for those hybrids c
ontaining up to 12 N-temimal HRG beta 1 residues. However, extending t
he N-terminal substitution to include to 20 HRG beta residues resulted
in a 100-fold drop in relative EGFR binding. Both interruption of the
major beta-sheet structure of hEGF by insertion of a three amino acid
loop present in HRG beta 1 and replacement of nearly the entire C-ter
minal hEGF subdomain w;ith segments of HRG beta 1 sequence resulted in
a 5-fold decreased EGFR affinity. The results presented here demonstr
ate that while a substantial protein of the hEGF and HRG beta 1 protei
n sequences were nearly interchangeable with regard to EGFR binding, t
he introduction of HRG beta 1 residue Glu195 effected a major decrease
in EGFR binding. (C) 1996 Academic Press.